# Verrica Pharmaceuticals Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:66a6cdca-0508-4fd6-98e3-0e463b13d302 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/verrica-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:55.096783+00:00 | | Last reviewed | 2026-10-17T04:46:55.096783+00:00 | ## Identity - Legal name: Verrica Pharmaceuticals Inc. - Display name: Verrica Pharmaceuticals Inc. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T04:46:55.096783+00:00 | | Completeness | 0.409 | | Record Quality | 0.841 | | Directors | 8 | | Committees | 6 | | Governance events | 18 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Charles Frantzreb: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5 - Diem Nguyen: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation · Chair (member); Compensation (chair). claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6 - Gavin Corcoran: Director. Status: current. Independent: true. Since: 2025-01-01. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7 - Jayson Rieger: Director. Status: current. Independent: false. Since: 2024-01-01. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8 - Lawrence Eichenfield: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (member); Audit; Compensation; Nominating and Governance · Chair (member); Compensation (member); Nominating and Governance (chair). claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9 - Mark Prygocki: Director. Status: current. Independent: true. Since: 2018-01-01. Committees: Audit (chair); Audit · Chair; Compensation; Nominating and Governance (member); Compensation (member); Nominating and Governance (member). claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10 - Paul B. Manning: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11 - Sean Stalfort: Director. Status: current. Independent: false. Since: 2015-01-01. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12 ## Committees - Audit (audit). Chair: Mark Prygocki. Members: Mark Prygocki (chair, current); Diem Nguyen (member, current); Lawrence Eichenfield (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:audit - Audit · Chair; Compensation; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Mark Prygocki (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:audit-chair-compensation-nominating-and-governance - Audit; Compensation · Chair (audit). Chair: NOT_PUBLISHED. Members: Diem Nguyen (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-chair - Audit; Compensation; Nominating and Governance · Chair (audit). Chair: NOT_PUBLISHED. Members: Lawrence Eichenfield (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:audit-compensation-nominating-and-governance-chair - Compensation (compensation). Chair: Diem Nguyen. Members: Diem Nguyen (chair, current); Lawrence Eichenfield (member, current); Mark Prygocki (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:compensation - Nominating and Governance (nominating_governance). Chair: Lawrence Eichenfield. Members: Lawrence Eichenfield (chair, current); Mark Prygocki (member, current). committee_id=alpha:committee:verrica-pharmaceuticals-inc:nominating-and-governance ## Executive leadership - David Zawitz: Chief Operating Officer, Chief Legal Officer and Secretary [GC]. Status: current. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13 - Jayson Rieger: Chief Executive Officer [CEO]. Status: current. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14 - John J. Kirby: interim Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15 - Noah Rosenberg: Chief Medical Officer. Status: current. claim_id=alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16 ## Governance events - GC_CHANGED: David Zawitz executive of Verrica Pharmaceuticals Inc., effective 2026-04-20. Effective: 2026-04-20. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:11867bg9bwnug - CEO_CHANGED: Jayson Rieger executive of Verrica Pharmaceuticals Inc., effective 2026-04-20. Effective: 2026-04-20. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:idqxh9cpd0zb - CFO_CHANGED: John J. Kirby executive of Verrica Pharmaceuticals Inc., effective 2026-04-20. Effective: 2026-04-20. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:cvzgfg8a2jau - EXECUTIVE_APPOINTED: Noah Rosenberg executive of Verrica Pharmaceuticals Inc., effective 2026-04-20. Effective: 2026-04-20. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1qda07m1p3tah6 - DIRECTOR_APPOINTED: Charles Frantzreb seat on Verrica Pharmaceuticals Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1seovo9mr0v6l - DIRECTOR_APPOINTED: Gavin Corcoran seat on Verrica Pharmaceuticals Inc., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1vc6ufxavdbab - DIRECTOR_APPOINTED: Jayson Rieger seat on Verrica Pharmaceuticals Inc., effective 2024-01-01. Effective: 2024-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:2ya3wp69czbl - DIRECTOR_APPOINTED: Diem Nguyen seat on Verrica Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:a9xpd51i1i2wf - DIRECTOR_APPOINTED: Lawrence Eichenfield seat on Verrica Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:s9xfzi10z1irs - COMMITTEE_CREATED: Audit; Compensation · Chair committee of Verrica Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1b1t5c3lkj8t7 - COMMITTEE_MEMBER_ADDED: Diem Nguyen member of Audit; Compensation · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:16v8kle1vpng4y - COMMITTEE_CREATED: Audit; Compensation; Nominating and Governance · Chair committee of Verrica Pharmaceuticals Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1xd9vfgb6l6n8 - COMMITTEE_MEMBER_ADDED: Lawrence Eichenfield member of Audit; Compensation; Nominating and Governance · Chair, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:u7x0ql2i6len - DIRECTOR_APPOINTED: Mark Prygocki seat on Verrica Pharmaceuticals Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:1a1cdab12hiejz - COMMITTEE_CREATED: Audit · Chair; Compensation; Nominating and Governance committee of Verrica Pharmaceuticals Inc., effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:sbfdfj1ixtsy7 - COMMITTEE_MEMBER_ADDED: Mark Prygocki member of Audit · Chair; Compensation; Nominating and Governance, effective 2018-01-01. Effective: 2018-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:ywckz88a374 - DIRECTOR_APPOINTED: Paul B. Manning seat on Verrica Pharmaceuticals Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:jkfmihhkxodj - DIRECTOR_APPOINTED: Sean Stalfort seat on Verrica Pharmaceuticals Inc., effective 2015-01-01. Effective: 2015-01-01. Detected: 2026-10-17T04:46:55.096783+00:00. event_id=alpha:event:transition:6j2n8popayg ## Scoped resources - `alpha://company/verrica-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record - `alpha://company/verrica-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/verrica-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/verrica-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=board - `alpha://company/verrica-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/verrica-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/verrica-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/verrica-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/verrica-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/verrica-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/verrica-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/verrica-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/verrica-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/verrica-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/verrica-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/verrica-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/verrica-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/verrica-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/verrica-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/verrica-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=events - `alpha://company/verrica-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/verrica-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/verrica-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:mark-prygocki","name":"Mark Prygocki"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:diem-nguyen","name":"Diem Nguyen"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lawrence-eichenfield","name":"Lawrence Eichenfield"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:diem-nguyen","name":"Diem Nguyen"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lawrence-eichenfield","name":"Lawrence Eichenfield"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:24: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:mark-prygocki","name":"Mark Prygocki"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:26: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:lawrence-eichenfield","name":"Lawrence Eichenfield"},"source_id":"board_seats"}` - Claim alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:mark-prygocki","name":"Mark Prygocki"},"source_id":"board_seats"}` ## Leadership - Charles Frantzreb: Director. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:5. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Diem Nguyen: Director, Audit; Compensation · Chair. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Gavin Corcoran: Director. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:7. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Jayson Rieger: Director. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:8. Valid from: 2024-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Lawrence Eichenfield: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:9. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Mark Prygocki: Director, Audit · Chair; Compensation; Nominating and Governance. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:10. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Paul B. Manning: Director. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:11. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - Sean Stalfort: Director. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:12. Valid from: 2015-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3. - David Zawitz: Chief Operating Officer, Chief Legal Officer and Secretary. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:13. Valid from: 2026-04-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d. - Jayson Rieger: Chief Executive Officer. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:14. Valid from: 2026-04-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014. - John J. Kirby: interim Chief Financial Officer. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:15. Valid from: 2026-04-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598. - Noah Rosenberg: Chief Medical Officer. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:leadership_role:16. Valid from: 2026-04-20. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Mark Prygocki; Members Mark Prygocki (Chair); Diem Nguyen; Lawrence Eichenfield. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Compensation: Chair Diem Nguyen; Members Diem Nguyen (Chair); Lawrence Eichenfield; Mark Prygocki. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Nominating and Governance: Chair Lawrence Eichenfield; Members Lawrence Eichenfield (Chair); Mark Prygocki. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_record:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Verrica Pharmaceuticals Inc.. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c778f97901b59b7cb9b3cd0f1a0842be1d4d0b6d07c2d8a3839aee2d80866011. ## Entity Status - Public listing published. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c778f97901b59b7cb9b3cd0f1a0842be1d4d0b6d07c2d8a3839aee2d80866011. ## Published Fact - US. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c778f97901b59b7cb9b3cd0f1a0842be1d4d0b6d07c2d8a3839aee2d80866011. ## Committee Appointment - Mark Prygocki: chair, Audit. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Diem Nguyen: member, Audit. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Lawrence Eichenfield: member, Audit. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Diem Nguyen: chair, Compensation. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Lawrence Eichenfield: member, Compensation. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Mark Prygocki: member, Compensation. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Lawrence Eichenfield: chair, Nominating and Governance. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. - Mark Prygocki: member, Nominating and Governance. Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999. ## Security Listing - VRCA (NASDAQ). Claim: alpha:claim:company:66a6cdca-0508-4fd6-98e3-0e463b13d302:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:c778f97901b59b7cb9b3cd0f1a0842be1d4d0b6d07c2d8a3839aee2d80866011. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:c778f97901b59b7cb9b3cd0f1a0842be1d4d0b6d07c2d8a3839aee2d80866011: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc). - alpha:projection-evidence:document:afcf04fc84e6d6a8f1411333b7a02d4d8f6cc5fd01c1c9f86b211b97a3e4bcc3: [Verrica Pharmaceuticals Inc. DEF 14A 2026-04-20](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). - alpha:projection-evidence:document:85f8ca39b8ac4dbfd3f93e713aec827f4bf814ea65998dc6d3a1b7f9131f2e2d: [VRCA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). - alpha:projection-evidence:document:36280718002bd96e364913c8ca83a43b10cb8862b25bcb350caa4a8e32dca014: [VRCA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). - alpha:projection-evidence:document:c242f5b0b98cb706a4421780e545a890faebb0056d7ea60186e8755846253598: [VRCA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). - alpha:projection-evidence:document:7c64aa543aeed0c5075d526e43946b46a6e4124eff0c547dc79afab09e70a01c: [VRCA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). - alpha:projection-evidence:43a60d33321e70fc9817426cabad41b0a3af49ade22376e3974b160742244999: [Audit](https://www.sec.gov/Archives/edgar/data/1660334/000119312526163961/d61950ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/verrica-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/verrica-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/verrica-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/verrica-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible. ## Critical-risk oversight Snapshot as of 2026-10-17T08:00:02.828379+00:00; recorded 2026-10-17T08:00:02.828379+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.